These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 10561228
1. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228 [Abstract] [Full Text] [Related]
2. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. Cancer; 2002 Jul 01; 95(1):147-54. PubMed ID: 12115328 [Abstract] [Full Text] [Related]
3. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Lim ST, Tupule A, Espina BM, Levine AM. Cancer; 2005 Jan 15; 103(2):417-21. PubMed ID: 15578686 [Abstract] [Full Text] [Related]
4. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R. J Clin Oncol; 1998 Mar 15; 16(3):1112-21. PubMed ID: 9508198 [Abstract] [Full Text] [Related]
5. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Stebbing J, Wildfire A, Portsmouth S, Powles T, Thirlwell C, Hewitt P, Nelson M, Patterson S, Mandalia S, Gotch F, Gazzard BG, Bower M. Ann Oncol; 2003 Nov 15; 14(11):1660-6. PubMed ID: 14581275 [Abstract] [Full Text] [Related]
6. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma. Kobayashi M, Takaori-Kondo A, Shindo K, Mizutani C, Ishikawa T, Uchiyama T. Intern Med; 2002 Dec 15; 41(12):1209-12. PubMed ID: 12521218 [Abstract] [Full Text] [Related]
7. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. Harrison M, Tomlinson D, Stewart S. J Clin Oncol; 1995 Apr 15; 13(4):914-20. PubMed ID: 7707119 [Abstract] [Full Text] [Related]
8. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. Evans SR, Krown SE, Testa MA, Cooley TP, Von Roenn JH. J Clin Oncol; 2002 Aug 01; 20(15):3236-41. PubMed ID: 12149296 [Abstract] [Full Text] [Related]
9. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study. Nasti G, Errante D, Talamini R, Rizzardini G, Fasan M, Landonio G, Zeroli C, Chichino G, Nigra E, Vaccher E, Tirelli U. J Clin Oncol; 2000 Apr 01; 18(7):1550-7. PubMed ID: 10735904 [Abstract] [Full Text] [Related]
11. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy. Schwartsmann G, Sprinz E, Kromfield M, Kalakun L, Sander E, Prolla G, Di Leone L, Gerhardt L, Mans DR. J Clin Oncol; 1997 May 01; 15(5):2118-24. PubMed ID: 9164226 [Abstract] [Full Text] [Related]
12. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. J Clin Oncol; 1998 Oct 01; 16(10):3369-74. PubMed ID: 9779714 [Abstract] [Full Text] [Related]
13. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study. Autier J, Picard-Dahan C, Marinho E, Grossin M, Yeni P, Leport C, Vildé JL, Crickx B, Descamps V. Br J Dermatol; 2005 May 01; 152(5):1026-9. PubMed ID: 15888164 [Abstract] [Full Text] [Related]
14. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. J Clin Oncol; 2000 Feb 01; 18(4):716-23. PubMed ID: 10673512 [Abstract] [Full Text] [Related]
15. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. J Clin Oncol; 1995 Apr 01; 13(4):996-1003. PubMed ID: 7707129 [Abstract] [Full Text] [Related]
16. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel. Hsu CH, Chen MY, Cheng AL. Anticancer Res; 2000 Apr 01; 20(2B):1159-61. PubMed ID: 10810414 [Abstract] [Full Text] [Related]
17. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. J Clin Oncol; 1996 Aug 01; 14(8):2353-64. PubMed ID: 8708728 [Abstract] [Full Text] [Related]
18. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa. Stein ME, Lachter J, Spencer D, Bezwoda WR. Int J Dermatol; 1995 Oct 01; 34(10):729-32. PubMed ID: 8537166 [Abstract] [Full Text] [Related]
19. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. Dupin N, Rubin De Cervens V, Gorin I, Calvez V, Pessis E, Grandadam M, Rabian C, Viard JP, Huraux JM, Escande JP. Br J Dermatol; 1999 May 01; 140(5):875-81. PubMed ID: 10354025 [Abstract] [Full Text] [Related]
20. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Aboulafia DM, Norris D, Henry D, Grossman RJ, Thommes J, Bundow D, Yocum RC, Stevens V. Arch Dermatol; 2003 Feb 01; 139(2):178-86. PubMed ID: 12588223 [Abstract] [Full Text] [Related] Page: [Next] [New Search]